LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic...

Clinical Pharmacology & Therapeutics 2012 / 8 Vol. 92; Iss. 2

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Zambrowicz, B, Freiman, J, Brown, P M, Frazier, K S, Turnage, A, Bronner, J, Ruff, D, Shadoan, M, Banks, P, Mseeh, F, Rawlins, D B, Goodwin, N C, Mabon, R, Harrison, B A, Wilson, A, Sands, A, Powell,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
92
Language:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1038/clpt.2012.58
Date:
August, 2012
File:
PDF, 564 KB
english, 2012
Conversion to is in progress
Conversion to is failed